Based in Delft, Bi/ond’s technology is already being deployed across The Netherlands and beyond, notably at Leiden University Medical Center, where clinicians are making heart tissues using Bi/ond’s microchips, and Erasmus University Medical Center, where researchers are developing breast cancer models that will eventually guide therapy selection. Bi/ond’s approach is to embrace human genetic variation in developing more inclusive and precision drugs for all populations . . .
Home Microfluidics To Infinity and Bi/ond: Microchips Underpin Dutch Goal to Make Drug Development...

To Infinity and Bi/ond: Microchips Underpin Dutch Goal to Make Drug Development More Inclusive
A Dutch organ-on-chip start-up aims to improve medical treatments by providing innovative hardware solutions that reflect humans’ natural diversity.
Dutch organ-on-chip start-up, Bi/ond has introduced the comPLATE™, a compact, reusable plate that is designed to be fully compatible with many perfusion systems. The plate can support separate microchips, including the inCHIPit™, for single or double perfusion as well as mechanical stimulation and imaging. Each complete can hold six inCHIPit microchips that can either be individually perfused or connected in series to create tissue interactions. [Bi/ond]